VRNA — VERONA PHARMA PLC

Ownership history in Caprock Group, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Caprock Group, LLC reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q3)
Avg. % of fund
0.01%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 6,395 +408 +6.8% 0.02% $677K —
2025 Q1 INITIATED 5,987 — — 0.01% $380K —
% of Fund (quarterly)

Other funds also holding VRNA

As of 2025 Q3 — sorted by position size

SYQUANT CAPITAL SAS 3Y 37.01% Twin Securities, Inc. 3Y 7Y 26.58% Vazirani Asset Management LLC 3Y 22.88% Aisling Capital Management LP 3Y 7Y 14.39% NEA Management Company, LLC 3Y 7Y 13.19% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 12.73% Chicago Capital Management, LLC 3Y 7Y 12.37% Vivo Capital, LLC 3Y 7Y 11.97% KRYGER CAPITAL Ltd 3Y 11.86% GLAZER CAPITAL, LLC 3Y 7Y 11.48%
← Back to Caprock Group, LLC Holdings